Press Release Jul. 10, 2017
As a branch of Ossur Group, Ossur China has witnessed a significant increase in its multi-level investment and distribution network since its establishment.
Since 2016, to sell products to customers nationwide directly, Ossur China has established Ossur (Shanghai) Commercial Trade Co., Ltd. to provide customers and terminal users with Ossur’s products with more advanced technologies and more competitive prices and consistently first-rate services.
SYMBIONIC® LEG 3 features the most advanced Ossur’s bionic technology and is the next generation of integrated-operation prosthetic device
As an industrial leader and pioneer, Ossur Group has opened Ossur Academy to cooperate actively with prosthesis distributors in different places and offered regular industrial training to prosthetists and spread the latest assembly concepts and industrial experience among them.
Ossur China also often invites foreign experts to give lectures in China. With its own quality resources, it provides more prosthetists with chances to study advanced technologies and improves the general level of China’s prosthesis industry.
The first awarding ceremony of Ossur Scholarship
Jan Kristen, technical supervisor of Ossur Asia-Pacific, is invited by Shaanxi Prosthesis Center to offer free voluntary diagnosis to amputees
In addition, Ossur Group is also a frequent visitor of different exhibitions. As one of the exhibitors, Ossur has achieved a good result at exhibitions with its lately developed new products such as Pro-Flex, Pro-Flex XC, Pro-Flex LP, Rheo Knee 3, Rheo Knee XC.
In 2016, Ossur Group focused on developing direct sales of prosthesis in China. It not only established Ossur (Shanghai) Commercial Trade Co., Ltd. to serve sales and assembly of prosthesis; it has also opened an exclusive clinic Inliven to provide more considerate services to amputees.
Ossur Inliven Clinic located in Shanghai, its Asia-Pacific headquarters
Adhering to the philosophy of “Life without Limitations”, Ossur Group has pursued a multi-dimensional development in the fields of prosthetics and orthotics and brought a better customer experience so that amputees can participate in social activities normally. It has also acquired and merged several renowned prosthetic enterprises such as the prosthesis business under “Medi” and “Touch Bionic”, with an aim to seek a bigger and stronger development in the industry.
Ten years have elapsed since Ossur entered China in 2006. We are convinced that in the near future, Ossur and its direct-sales team of prosthesis will bring more surprises and expectations to us.